Latest Stories

Don’t miss our hot and upcoming stories
Is AI-Engineered HMBD-002 the Next Big Immunotherapy? Hummingbird Bioscience Signs $290M Global Licensing Deal with Percheron Therapeutics

Key Highlights Strategic Global Licensing Deal Hummingbird Bioscience has signed a worldwide licensing agreement with…

ByByAnuja Singh Jun 26, 2025
Can ProFound Therapeutics and Novartis’ $750M AI-Driven Cardiovascular Pact Redefine Drug Discovery from the Human Proteome?

Key Highlights AI Meets Proteomics: A New Paradigm in Cardiovascular DiscoveryIn a bold step toward…

ByByAnuja Singh Jun 26, 2025
Is Insilico’s AI-Driven UAE University Alliance the Catalyst for a New Generation of Biotech Talent?

Key Highlights Academic Meets AI Innovation in UAEInsilico Medicine, a leader in generative AI for…

ByByAnuja Singh Jun 25, 2025
How Abridge’s $5.3B AI Surge Is Transforming Clinical Documentation and Revenue Cycles in U.S. Healthcare

Key Insights: Andreessen Horowitz Leads $300M Bet on Abridge’s Healthcare AI VisionAndreessen Horowitz (A16z) has…

ByByAnuja Singh Jun 25, 2025
Scroll to Top